Morgan Stanley Initiates Coverage On Cabaletta Bio with Overweight Rating, Announces $19 Price Target

Morgan Stanley initiates coverage on Cabaletta Bio (NASDAQ:CABA) with a Overweight rating and a $19 price target.

Benzinga · 11/19/2019 13:41

Morgan Stanley initiates coverage on Cabaletta Bio (NASDAQ:CABA) with a Overweight rating and a $19 price target.